[Serum resistance and "nephropathogenicity" of E. coli. IV. Changes of virulence in vitro and in vivo].
D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D001770:Blood Bactericidal Activity; D002701:Chloramphenicol / Q000494:pharmacology; D002908:Chronic Disease; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000150:complications; D005260:Female; D009268:Nalidixic Acid / Q000494:pharmacology; D010403:Penicillin Resistance; D011704:Pyelonephritis / Q000209:etiology / Q000382:microbiology; D051381:Rats; D013307:Streptomycin / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014774:Virulence / Q000187:drug effects
D013449:Sulfonamides; D009268:Nalidixic Acid; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D013307:Streptomycin